Will ChrysCap beat benchmark returns again in second exit from Mankind Pharma?

 Will ChrysCap beat benchmark returns again in second exit from Mankind Pharma?
Indian private equity firm ChrysCapital has lined up a partial exit from Mankind Pharma, four years after returning to back the drugmaker after a previous exit. The partial exit comes at a time when ChrysCapital, one of the biggest Indian PE firms, is on the road to seek capital commitments […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest